Aclarion Stock Investor Sentiment

ACON Stock  USD 7.12  0.29  3.91%   
About 64% of Aclarion's investor base is looking to short. The analysis of overall sentiment of trading Aclarion stock suggests that many investors are alarmed at this time. Aclarion's investing sentiment overview a quick insight into current market opportunities from investing in Aclarion. Many technical investors use Aclarion stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Aclarion Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aclarion can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Aclarion's Stock prices. Below is the latest headlines and news related to Aclarion Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Aclarion that are available to investors today. This information is accessible both publicly - through Aclarion's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Aclarion-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Aclarion news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aclarion relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aclarion's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aclarion alpha.

Aclarion Largest EPS Surprises

Earnings surprises can significantly impact Aclarion's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-14
2023-09-30-0.09-0.117-0.02730 
2023-07-03
2023-06-30-0.1-0.15-0.0550 
2022-11-14
2022-09-30-0.12-0.21-0.0975 
2024-05-15
2024-03-31-0.57-0.440.1322 
2022-08-15
2022-06-30-0.11-0.49-0.38345 
2025-04-09
2025-03-31-0.17-9.32-9.155382 
View All Earnings Estimates
a day ago at news.google.com         
What analysts say about Aclarion Inc. stock - High-profit stock alerts - Jammu Links News
Google News at Macroaxis
2 days ago at news.google.com         
Is Aclarion Inc. Equity Warrant a good long term investment - Overwhelming financial success - Jammu...
Google News at Macroaxis
over a week ago at gurufocus.com         
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders ACON Stock News
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Aclarion Begins Patient Enrollment in Clarity Trial for Nociscan ACON Stock News
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
First Patient Enrolled in Aclarions Groundbreaking CLARITY Trial ACON Stock News
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum ACON Stock News
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Aclarion Showcases NOCISCAN at Spine Surgery Conference ACON Stock News
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site ...
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Aclarion Expands CLARITY Trial with University of Miami Health System ACON Stock News
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Aclarion Raised to Hold at Wall Street Zen
news
over a month ago at news.google.com         
Aclarion stock price target cut to 20 at Ascendiant Capital By Investing.com - Investing.com India
Google News at Macroaxis
over two months ago at gurufocus.com         
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site ACON Stock News
Gurufocus Stories at Macroaxis
over two months ago at gurufocus.com         
Aclarion Announces Texas Back Institute as New CLARITY Trial Site ACON Stock News
Gurufocus Stories at Macroaxis
over two months ago at gurufocus.com         
Aclarion Expands CLARITY Trial with Texas Back Institute ACON Stock News
Gurufocus Stories at Macroaxis
over two months ago at gurufocus.com         
Aclarion Welcomes Advocate Health as CLARITY Trial Site ACON Stock News
Gurufocus Stories at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Aclarion that are available to investors today. This information is accessible both publicly - through Aclarion's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Aclarion-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Aclarion news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aclarion relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aclarion's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aclarion alpha.

Aclarion Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Aclarion Inc Files For Mixed Shelf Of Up To 150 Mln - SEC Filing - marketscreener.com
04/25/2025
2
Aclarion Announces Texas Back Institute as New CLARITY Trial Site ACON Stock News
05/12/2025
3
Aclarion Raised to Hold at Wall Street Zen
06/02/2025
4
Aclarion Showcases NOCISCAN at Spine Surgery Conference ACON Stock News
06/24/2025
5
Aclarion Begins Patient Enrollment in Clarity Trial for Nociscan ACON Stock News
06/25/2025
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports:
Check out Aclarion Hype Analysis, Aclarion Correlation and Aclarion Performance.
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.50)
Revenue Per Share
0.094
Quarterly Revenue Growth
0.878
Return On Assets
(0.35)
Return On Equity
(0.73)
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.